Epidemiology of prostate cancer, its determinants and prevention
DOI:
https://doi.org/10.19230/jonnpr.3686Keywords:
prostate cancer, risk, incidence, preventionAbstract
Introduction. Prostate cancer is the most common among the male population worldwide. Due to early diagnosis and to improvements in the treatment, in the past 25 years, the survival rate has increased to 5 years.
Objective. To assess the knowledge, risk factors and prevention of prostate cancer.
Methodology. We conducted a cross-sectional descriptive study, a semi-structured survey and anonymous nature of the Quartermaster staff of the Institute of Health Sciences.
Results. 50 surveys were applied, the most frequent age range was 40 to 50 years, the primary level of schooling was secondary. The 25% of the population said to have an average knowledge about prostate cancer and the 50% of the population said they did not go back to studies can be carried out for fear of the urologist.
Conclusion. There is a lack of information about prostate cancer, so it is necessary to provide health education to the male population and encourage the testing of prostate cancer to achieve an early diagnosis. Otherwise a late result implies a negative health condition.
Downloads
References
Sotelo Martínez, L., & Sánchez Luna, C. (2014). Cáncer de próstata: guía radiológica. Medigraphic, 13, 230-245.
Álvarez-Blanco , M., Escudero de los Ríos , P., & Hernández Toríz , N. (2008). Cáncer de próstata. Medigraphic, 68(4), 250-259.
Salud, I. A. (Septiembre de 2008). Guiasalud.es. Recuperado el 22 de Febrero de 2018, de Guiasalud.es:
http://www.guiasalud.es/GPC/GPC_431_Ca_Prostata_ICS_resum.pdf
Ruiz López, A. I., Pérez Mesa, J. C., Cruz Bautista, Y., & González Lorenzo, L. E. (2017). Actualización sobre cáncer de próstata. Scielo, 21(3).
Álvarez-Blanco , M., Escudero de los Ríos , P., & Hernández Toríz , N. (2008). Cáncer de próstata. Medigraphic, 68(4), 250-259.
INSP. (24 de FEBRERO de 2018). Obtenido de GOB.MX: https://www.insp.mx/avisos/4189-cancer-prostata- mx.html
A. Heidenreich (presidente), M. B.-P. (24 de FEBRERO de 2018). Guía clínica sobre el cáncer de próstata. Obtenido de http://www.aeu.es/UserFiles/01-GUIA_CLINICA_SOBRE_EL_CANCER_DE_PROSTATA.pdf.
Pedro Rizo Ríos, A. G. (2015). Tendencia de la mortalidad por cáncer en México. Evid Med Invest Salud, 8-11.
MenesesA.M.Palmeros-RodríguezL.Trujillo-OrtizJ.Gómez-SánchezJ.A.Herrera-MuñozD.A.Preciado-EstrellaM.Cantellano-OrozcoC.Martínez-ArroyoJ.G.Morales-MontorC.Pacheco-Gahble, J.-B.-G.-S.-D.-T. d. (2016). Epidemiología de los tumores genitourinarios en una décadaA decade of genitourinary tumor epidemiology. Revista mexicana de urologia, 131-140.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
